Food and Drug Administration News and Analysis
News and updates covering the U.S. Food and Drug Administration. As the agency tasked with regulating the safety of medical devices and pharmaceutical products, the FDA has sought to embrace the efficiencies provided by digital modernization. This has included a special focus on incorporating AI and machine-learning capacities toward drug development and pharmaceutical research, as well as the FDA’s ongoing research and development into applying technologies like 3D printing toward manufacturing medical supplies amid the COVID-19 epidemic.
Vid Desai discusses FDA's next stage of IT transformation.
Newly confirmed CIO Vid Desai discusses how his role has evolved following the creation of FDA's Digital Transformation Office.
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
FDA is tackling security measures for the health technologies it regulates.
CTO Vid Desai brings private sector successes to meeting agency missions.
With technology changing by the second, the agency's new center of excellence aims to keep medical software and devices safe for patients.
The agency is looking to digital tools and automation to streamline regulatory decisions in health.
The agency is updating its guidance around vaccine authorization and will require investments in technology for its distribution.
The acting CIO shared insights into the agency's pandemic response and lessons learned so far.
The group will consolidate data and resources to research and develop COVID-19 pharmaceutical solutions.
Technological solutions could provide relief to medical facilities in urgent need of necessary equipment.
The technology is one way to solve national shortages of medical supplies during the COVID-19 pandemic.
The molecular diagnostics test is the fastest test for the novel coronavirus in the U.S.
Global health leaders are calling attention to the world's other leading infectious diseases like tuberculosis.
Data can accelerate the approval processes for new drugs and medical devices.
A GAO report highlights policy areas as the FDA considers regulatory rules around the technology.
Agencies find opportunity in increasing diversity within cyber programs and leveraging shared services.
Health agencies point to a need for modernized IT infrastructure and data-driven decisions.
The emerging technologies can predict, anticipate and protect against dangerous chemicals in the U.S. food supply.